Search results
Results from the WOW.Com Content Network
At the beginning of 2011, DePuy Orthopaedics said they were phasing out the ASR Hip Implant because of declining sales, but never mentioned the high failure rate data from an Australian implant registry. In March 2011, The New York Times reported that DePuy issued its first warning to doctors and patients about the high early failure rate. [1]
DePuy has 15 days to notify the FDA of the specific steps it has taken to correct the violations. It also wants an explanation of how the company plans to prevent these violations or similar ones ...
On August 24, 2010, DePuy recalled [4] all ASR hip implant systems sold since 2003. The 2010 DePuy Hip Recall was issued after research released by the National Joint Registry (NJR) found high rates of hip replacement failure for the ASR XL Acetabular and ASR Hip Resurfacing systems.
On August 24, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%. All hip prostheses ...
For premium support please call: 800-290-4726 more ways to reach us
The biggest consumer product recall of 2010, it turned out, should not have been a recall at all. But a dozen recalls involved more than 1 million products apiece and left consumers scrambling to ...
2010 DePuy Hip Recall; 2010 Johnson & Johnson children's product recall; B. Born Rich (2003 film) C. Chicago Tylenol murders; D. Doctor Dan the Bandage Man; G.
Johnson & Johnson (JNJ) has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges that could lead to serious health ...